Correlates of cerebrospinal fluid levels of oligomeric- and total-α-synuclein in premotor, motor and dementia stages of Parkinson’s disease-Reference-Cited by-同舟云学术

Correlates of cerebrospinal fluid levels of oligomeric- and total-α-synuclein in premotor, motor and dementia stages of Parkinson’s disease

Published:2014-11-08 Issue:2 Volume:262 Page:294-306
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Compta Yaroslau,Valente Tony,Saura Josep,Segura Bàrbara,Iranzo Álex,Serradell Mònica,Junqué Carme,Tolosa Eduard,Valldeoriola Francesc,Muñoz Esteban,Santamaria Joan,Cámara Ana,Fernández Manel,Fortea Juan,Buongiorno Mariateresa,Molinuevo José Luis,Bargalló Núria,Martí María José

Publisher

Springer Science and Business Media LLC

Subject

Clinical Neurology,Neurology

Link

http://link.springer.com/content/pdf/10.1007/s00415-014-7560-z.pdf

Reference45 articles.

1. Mollenhauer B (2014) Quantification of α-synuclein in cerebrospinal fluid: how ideal is this biomarker for Parkinson’s disease? Parkinsonism Relat Disord 20(Suppl 1):S76–S79

2. Magdalinou N, Lees AJ, Zetterberg H (2014) Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions. J Neurol Neurosurg Psychiatry 85:1065–1075

3. Tolosa E, Gaig C, Santamaría J, Compta Y (2009) Diagnosis and the premotor phase of Parkinson disease. Neurology 72:S12–S20

4. Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211

5. Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG (2008) The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. Mov Disord 23:837–844

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma level of alpha-synuclein oligomers as a biomarker for isolated rapid eye movement sleep behavior disorder diagnosis and progression: a prospective cohort study;Frontiers in Neurology;2024-08-23

2. Serum Oligomeric α-Synuclein and p-tau181 in Progressive Supranuclear Palsy and Parkinson’s Disease;International Journal of Molecular Sciences;2024-06-23

3. Evaluating the Diagnostic Potential of Combined Salivary and Skin Biomarkers in Parkinson’s Disease;International Journal of Molecular Sciences;2024-04-28

4. Fluid and tissue biomarkers in Parkinson’s disease: Immunodetection or seed amplification? Central or peripheral?;Parkinsonism & Related Disorders;2023-12

5. Cerebrospinal-fluid biomarkers for predicting phenoconversion in patients with isolated rapid-eye movement sleep behavior disorder;SLEEP;2023-08-05